Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis - PubMed (original) (raw)
Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis
S L Gottlieb et al. Nat Med. 1995 May.
Abstract
Psoriasis is a hyperproliferative and inflammatory skin disorder of unknown aetiology. A fusion protein composed of human interleukin-2 and fragments of diphtheria toxin (DAB389IL-2), which selectively blocks the growth of activated lymphocytes but not keratinocytes, was administered systemically to ten patients to gauge the contribution of activated T cells to the disease. Four patients showed striking clinical improvement and four moderate improvement, after two cycle of low dose IL-2-toxin. The reversal of several molecular markers of epidermal dysfunction was associated with a marked reduction in intraepidermal CD3+ and CD8+ T cells, suggesting a primary immunological basis for this widespread disorder.
Similar articles
- Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes.
Bousvaros A, Stevens AC, Strom TB, Murphy J, Lamont JT. Bousvaros A, et al. Dig Dis Sci. 1997 Jul;42(7):1542-8. doi: 10.1023/a:1018891432581. Dig Dis Sci. 1997. PMID: 9246061 - DAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice.
Bhopale MK, Hilliard B, Constantinescu CS, Phillips SM, Rostami A. Bhopale MK, et al. Immunopharmacol Immunotoxicol. 2017 Dec;39(6):318-329. doi: 10.1080/08923973.2017.1369099. Epub 2017 Sep 20. Immunopharmacol Immunotoxicol. 2017. PMID: 28929835 Free PMC article. - Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation.
Walz G, Zanker B, Brand K, Waters C, Genbauffe F, Zeldis JB, Murphy JR, Strom TB. Walz G, et al. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9485-8. doi: 10.1073/pnas.86.23.9485. Proc Natl Acad Sci U S A. 1989. PMID: 2594781 Free PMC article. - Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma.
Foss FM. Foss FM. Ann N Y Acad Sci. 2001 Sep;941:166-76. doi: 10.1111/j.1749-6632.2001.tb03720.x. Ann N Y Acad Sci. 2001. PMID: 11594570 Review. - Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.
Tonel G, Conrad C. Tonel G, et al. Int J Biochem Cell Biol. 2009 May;41(5):963-8. doi: 10.1016/j.biocel.2008.10.022. Epub 2008 Nov 5. Int J Biochem Cell Biol. 2009. PMID: 19027868 Review.
Cited by
- Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.
Wolf P, Nghiem DX, Walterscheid JP, Byrne S, Matsumura Y, Matsumura Y, Bucana C, Ananthaswamy HN, Ullrich SE. Wolf P, et al. Am J Pathol. 2006 Sep;169(3):795-805. doi: 10.2353/ajpath.2006.060079. Am J Pathol. 2006. PMID: 16936256 Free PMC article. - [Psoriatic arthritis : a permanent challenge for rheumatologists and patients--Part 1: epidemiology, pathogenesis and clinical course].
Finzel S, Englbrecht M. Finzel S, et al. Z Rheumatol. 2011 Oct;70(8):685-97. doi: 10.1007/s00393-011-0860-0. Z Rheumatol. 2011. PMID: 21912984 Review. German. - Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.
Gill AJ, Kolson DL. Gill AJ, et al. Crit Rev Immunol. 2013;33(4):307-59. doi: 10.1615/critrevimmunol.2013007247. Crit Rev Immunol. 2013. PMID: 23971529 Free PMC article. Review. - TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis.
Wang H, Peters T, Sindrilaru A, Kess D, Oreshkova T, Yu XZ, Seier AM, Schreiber H, Wlaschek M, Blakytny R, Röhrbein J, Schulz G, Weiss JM, Scharffetter-Kochanek K. Wang H, et al. J Clin Invest. 2008 Jul;118(7):2629-39. doi: 10.1172/JCI34916. J Clin Invest. 2008. PMID: 18521187 Free PMC article. - Dermal injection of immunocytes induces psoriasis.
Wrone-Smith T, Nickoloff BJ. Wrone-Smith T, et al. J Clin Invest. 1996 Oct 15;98(8):1878-87. doi: 10.1172/JCI118989. J Clin Invest. 1996. PMID: 8878440 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials